Cargando…
Treatment of patients with type 2 diabetes and non-alcoholic fatty liver disease: current approaches and future directions
Non-alcoholic fatty liver disease (NAFLD) is reaching epidemic proportions in patients with type 2 diabetes. Patients with NAFLD are at increased risk of more aggressive liver disease (non-alcoholic steatohepatitis [NASH]) and at a higher risk of death from cirrhosis, hepatocellular carcinoma and ca...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4861748/ https://www.ncbi.nlm.nih.gov/pubmed/27101131 http://dx.doi.org/10.1007/s00125-016-3952-1 |